Solly Chedid, MD, presents a case of a patient with lower-risk MDS and provides clinical insights on the first-line use of an erythroid maturating agent. Jamie L. Koprivnikar, MD, presents a case of a ...

Expert Rev Hematol. 2008;1(2):217-229. Another important issue is prevention of osteoporosis in CIN patients. Apart from the conventional bone-mineral density measurement, we recommend evaluation ...

The Bangladesh Securities and Exchange Commission (BSEC) is working to form a committee for reducing time maturing ...